國內肝硬化患者約有50萬人，根據研究，民眾在感染C肝之後，有八成會轉變成慢性肝炎，兩、三成進展成肝硬化，患者進一步演變成肝癌的機率都相當高。今年健保擴大給付C肝新藥治療後，許多民眾因此受惠，一名65歲簡女士20年前曾接受干擾素治療，以為已經根治，直到半年前出現手麻、嗜睡症狀，才驚覺肝硬化嚴重，在接受口服新藥治療後，目前已完全清除，而且過程幾乎沒有副作用。 (C肝病友 簡女士 差不多20年前，我有吃(干擾素)會發冷，會吐頭會暈，但是這一次吃之後都沒有，只覺得說走平路的時候，會覺得有點無力，不然其實沒有什麼副作用。) 另一名同樣是C肝病友的黃先生，病史15年，甚至演變成肝癌，所幸在投入Ｃ肝治療以後，身體狀況明顯好轉，肝癌病情也在控制範圍內。 (C肝病友 黃先生 差別就是，之前都沒辦法走，要走去車庫2、30公尺，都走不動，快喘不過氣，現在已經可以走3000(公尺)身體狀況跟體力，已經明顯的差別。) 不過主治醫師表示，雖然口服新藥能夠有效降低病毒數，改善肝纖維化的指數，但還是要看肝癌的階段，因此提醒民眾及早投入治療。 (胃腸肝膽科主任 黃怡翔 比如說他的肝癌還是在早期，或中期的一個情況，這種的話他的目前的肝癌，應該可以用現有的一個治療方式得到控制，那如果我們讓他的C型肝炎持續地發炎的話，事實上反而會阻礙我們對肝癌的一個治療的一個選擇，所以在這種的考量之下，那這樣的Ｃ肝如果還是病毒很活躍，那應該還是要積極的一個治療。) 今年健保給付一萬五千多名額中，已使用了8成，有需要的民眾可以趕緊到就近的醫療院所尋求治療，黃怡翔也表示，目前國內目標在2030年消滅C肝，因此如果政府預算充裕，降低纖維化門檻，讓病友及早投入治療，也可降低其他民眾感染機率。
About 500,000 people with liver cirrhosis in China, according to the study, after the infection of C liver, 80% will be converted into chronic hepatitis, two or three percent progress to cirrhosis, and the probability of further evolution into liver cancer is quite high. After the health care plan was expanded this year, many people benefited from the treatment of C-hepatitis drugs. A 65-year-old Ms. Jane was treated with interferon 20 years ago. She thought that she had been cured. She was diagnosed with cerebral cirrhosis until she developed symptoms of hand numbness and lethargy six months ago. Severe, after receiving oral new drug treatment, it has been completely eliminated, and the process has almost no side effects. (C liver disease friend Ms. Jane almost 20 years ago, I have to eat (interferon) will be cold, will vomit will faint, but this time after eating, there is no, just feel that when going to the road, it will feel a little weak, Otherwise, there is no side effect.) Another Mr. Huang, who is also a C-hepatitis patient, has a history of 15 years and even evolved into liver cancer. Fortunately, after he was put into C-hepatitis treatment, his physical condition improved significantly and his liver cancer was also under control. (The difference between Mr. Huang and Mr. Huang is that there is no way to go before, go to the garage 2, 30 meters, can't walk, can't breathe, and now you can walk 3000 (meter) physical condition and physical strength, already obvious The difference.) However, the attending physician said that although oral administration of new drugs can effectively reduce the number of viruses and improve the index of liver fibrosis, it still depends on the stage of liver cancer, so remind people to put into treatment as soon as possible. (Director of the Gastrointestinal Hepatobiliary Department, Huang Yixiang, said that his liver cancer is still in the early or middle stage. In this case, his current liver cancer should be controlled by an existing treatment method, then if we let his hepatitis C Sustained inflammation, in fact, will hinder our choice of a treatment for liver cancer, so under such considerations, if such a C liver is still very active, it should still be a positive treatment.) This year, health insurance has paid more than 15,000 yuan, and 80% of it has been used. People in need can hurry to the nearest medical institution to seek treatment. Huang Yixiang also said that the current domestic goal is to eliminate C liver in 2030, so if the government budget Adequate, lowering the threshold of fibrosis, allowing patients to be treated early, can also reduce the chance of infection among other people.
Laennec is the ethical drug manufactured with JBP’s unique technologies.
Laennec is the ethical drug manufactured with JBP’s unique technologies for effective extraction of variety of growth factors, cytokines, and other physiologically active substances from the human placenta. For instance, HGF (hepatocyte growth factor) promotes the proliferation of hepatic parenchymal cells for recovery of a damaged liver. Our product safety is ensured by the most rigid safety measures among existing scientific standards.
留言列表
